|Hello there, |
The world’s attention is on India this month as it struggles with a catastrophic second wave of Covid-19 infections.
Emergency medical aid from the rest of the world is pouring into the country at a level not seen since the 2004 Boxing Day tsunami. The resounding response is commendable, but as a whole, cooperation among the community of nations has been a mixed bag since the global pandemic began.
In this edition of Global Impact, Bhavan Jaipragas, our senior Asia correspondent, will examine how countries have fared in assisting others – and accepting much needed help – in this crisis of a generation.
All the best,
Senior Editor, Political Economy
The China-India relationship has not exactly been balmy of late, with tensions spiking with increasing regularity over the two countries’ disputed border and New Delhi’s involvement in the US-led Quad arrangement.
Nonetheless, Beijing has shown it is ready to put aside these prickly issues to offer India the help it needs as the South Asian nation’s Covid-19 disaster worsens. In India, that olive branch has been met in some quarters with scepticism, with cynics wondering if China’s outreach contained a “hidden agenda”.
This was put on display with the lack of Indian participation in a recent conference call on coordinating emergency supplies between the Chinese Foreign Minister Wang Yi and counterparts from South Asian nations Afghanistan, Pakistan, Nepal, Sri Lanka and Bangladesh.
India’s standoffishness towards China’s helping hand is not isolated; across Asia, China’s widening vaccine diplomacy has been met with varying degrees of suspicion.
In Singapore, for example, the arrival in February of China-made Sinovac vaccines before they had received domestic approval raised questions about whether the shipment was a tacit form of “pressure” from Beijing for the city state to quickly green light the jabs.
Observers say there is greater appreciation for China’s efforts among developing economies, which are bearing the brunt of rich nations’ vaccine nationalism. Figures compiled by the Post in early April showed China had by then shipped more than 80 million ready made vaccine doses overseas.
Recipients include the tiny South American country Guyana, landlocked Laos in Southeast Asia, and Zimbabwe in Africa.
A major challenge for China’s vaccine diplomacy has been confusion over the efficacy data surrounding its jabs.
The new release of data and assessments by the World Health Organization will go some way in quelling these concerns, but there remain doubts about the Chinese vaccines’ safety and efficacy for high-risk groups and the elderly.
Political watchers say the decision by foreign governments – namely Malaysia, Indonesia and the United Arab Emirates – to begin domestic production of Chinese vaccines is an important shot in the arm for Beijing’s vaccine diplomacy effort.
In Indonesia, the joint efforts have been portrayed as an important step in combating the global “vaccination divide”.
For now, what is clear is that countries, especially in Asia, cannot afford to stand alone. Fierce new Covid-19 waves are enveloping other developing countries across the region, placing severe strain on their health care systems and prompting appeals for help.
The US this week appeared to be taking a step in the right direction in this regard, signalling it will back an Indian and South African initiative to waive intellectual property protections for Covid-19 vaccines.
As the Chinese international relations professor Zha Daojiong put it recently, major powers the US and China would do well to step up their vaccine diplomacy in tandem with each other. The real battle for benefactor nations is to not to outdo one another, but to act quickly to save lives.